Search results
Benjamin Scott
Job title: MD
Author
Added:
5 months ago
Source:
Radcliffe CVRM
A post hoc analysis of the STRIDE trial has found that once-weekly semaglutide 1.0 mg consistently improves functional outcomes in people with early symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D), irrespective of sex.¹˒²This analysis addresses the need for sex-specific data in PAD, where differences in epidemiology, clinical presentation, and treatment response are…
View more
Elisa Liehn
Author
Xiao Liu
Author
Xiaomeng Wang
Research Area(s) / Expertise:
Author
Bharat K Kantharia
Author
Rachael Hii
Author
Leng Shuang
Author
Sumanto Mukhopadhyay
Author
Yohei Ohno
Job title: Director of Valve and Structural Heart Intervention Program
Author